chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nasal pruritus, Oral pruritus, Pruritus
Clinical narrative: Itchy ears; Itchy nose; itchy face; Itchy mouth; Muscle pain; Joint pain; Flowing lips; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face) and ORAL PRURITUS (Itchy mouth) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION COMPLICATION (Flowing lips). On 29-Jan-2021, the patient experienced PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and DICLOFENAC RESINATE (ZOTAC) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Itchy ears; Itchy nose; itchy face; Itchy mouth; Muscle pain; Joint pain; Flowing lips; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face) and ORAL PRURITUS (Itchy mouth) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION COMPLICATION (Flowing lips). On 29-Jan-2021, the patient experienced PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and DICLOFENAC RESINATE (ZOTAC) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Flowing lips), PRURITUS (Itchy ears), NASAL PRURITUS (Itchy nose), PRURITUS (itchy face), ORAL PRURITUS (Itchy mouth), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: severe body ache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills). At the time of the report, MYALGIA (severe body ache), PYREXIA (fever) and CHILLS (chills) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout attack; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout attack) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Gout, Hypertension, Cholesterol and Asthma. Concomitant products included MONTELUKAST for Asthma, ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol, ALOPURINOL for Gout, BENAZEPRIL for Hypertension.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced GOUT (gout attack). At the time of the report, GOUT (gout attack) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment medication was taken by patient but doctor prescribed Colchicine.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: I just recently had COVID 11 days after I've been vaccinated with your product; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product). At the time of the report, COVID-19 (I just recently had COVID 11 days after I've been vaccinated with your product) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: red patch at the injection site; arm itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy). At the time of the report, VACCINATION SITE ERYTHEMA (red patch at the injection site) and VACCINATION SITE PRURITUS (arm itchy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site rash
Clinical narrative: Lump at injection site; Redness at injection site; Rash at injection site; Soreness in her arm after the injection; This spontaneous case was reported by a consumer and describes the occurrence of   in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Slight movement pain in the same arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection). At the time of the report, VACCINATION SITE PAIN (Slight movement pain in the same arm of the injection) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Erythema, Heat exhaustion, Joint swelling
Clinical narrative: Arm very sore; Tenderness in joints; Swelling in joints; Pain in the armpit; Arm very red; Arm warm to the touch; Achenes in joints; Heat in the armpit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit) and ERYTHEMA (Arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit). At the time of the report, PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tenderness, Vaccination site warmth
Clinical narrative: Arm very sore; Tenderness in joints; Swelling in joints; Pain in the armpit; Arm very red; Arm warm to the touch; Achenes in joints; Heat in the armpit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit) and ERYTHEMA (Arm very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit). At the time of the report, PAIN IN EXTREMITY (Arm very sore), TENDERNESS (Tenderness in joints), JOINT SWELLING (Swelling in joints), AXILLARY PAIN (Pain in the armpit), ERYTHEMA (Arm very red), VACCINATION SITE WARMTH (Arm warm to the touch), ARTHRALGIA (Achenes in joints) and HEAT EXHAUSTION (Heat in the armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Reporting a side effects from the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Reporting a side effects from the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Reporting a side effects from the vaccine). At the time of the report, ADVERSE EVENT (Reporting a side effects from the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Fever / Fever of 38 degrees; fever; Chills; Fatigued; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of   in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 38 (Inconclusive) Fever of 38 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Symptomatic COVID Positive Test Post First Dose) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced COVID-19 (Symptomatic COVID Positive Test Post First Dose). On 02-Feb-2021, COVID-19 (Symptomatic COVID Positive Test Post First Dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Injection Site reactions are getting worst; itching on the Injection Site; Injection Site looks like Bee-Sting; Swollen Injection Site; Red Injection Site 2; A little Sore Throat; More sore at the injection site; Little Soreness at the Injection Site; Redness at the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Little Soreness at the Injection Site), ERYTHEMA (Redness at the Injection Site), INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site) and INJECTION SITE REACTION (Injection Site looks like Bee-Sting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site). On 29-Jan-2021, the patient experienced INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site). On 23-Jan-2021, ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site) had resolved. At the time of the report, INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Injection site swelling, Oropharyngeal pain
Clinical narrative: Injection Site reactions are getting worst; itching on the Injection Site; Injection Site looks like Bee-Sting; Swollen Injection Site; Red Injection Site 2; A little Sore Throat; More sore at the injection site; Little Soreness at the Injection Site; Redness at the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Little Soreness at the Injection Site), ERYTHEMA (Redness at the Injection Site), INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site) and INJECTION SITE REACTION (Injection Site looks like Bee-Sting) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site). On 29-Jan-2021, the patient experienced INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site). On 23-Jan-2021, ARTHRALGIA (Little Soreness at the Injection Site) and ERYTHEMA (Redness at the Injection Site) had resolved. At the time of the report, INJECTION SITE REACTION (Injection Site reactions are getting worst), INJECTION SITE PRURITUS (itching on the Injection Site), INJECTION SITE REACTION (Injection Site looks like Bee-Sting), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE ERYTHEMA (Red Injection Site 2), OROPHARYNGEAL PAIN (A little Sore Throat) and INJECTION SITE PAIN (More sore at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Pain, Pyrexia
Clinical narrative: Everything hurts; Sweats; Horrible fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills). At the time of the report, PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Pyrexia: 92 (Inconclusive) 92F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills). At the time of the report, PAIN (Everything hurts), HYPERHIDROSIS (Sweats), FATIGUE (Horrible fatigue) and CHILLS (Chills) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Pyrexia: 92 (Inconclusive) 92F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included antidepressants.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). On 01-Feb-2021, CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. Not Provided          No medical history, concomitant medication or treatment information was reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Injection site erythema, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: SKIN DECOLORATION; HOT TO THE TOUCH INJECTION SITE; ITCHINESS AT INJECTION SITE; RASH AT INJECTION SITE; REDNESS AT INJECTION SITE; SHORTNESS OF BREATH; HEART PALPITATIONS; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE) and INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medically reported history provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE). On 28-Jan-2021, the patient experienced SKIN DISCOLOURATION (SKIN DECOLORATION). The patient was treated with CORTISONE at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: An additional document received on 16 Apr 2021 included reported email address updated
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Skin discolouration
Clinical narrative: SKIN DECOLORATION; HOT TO THE TOUCH INJECTION SITE; ITCHINESS AT INJECTION SITE; RASH AT INJECTION SITE; REDNESS AT INJECTION SITE; SHORTNESS OF BREATH; HEART PALPITATIONS; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE) and INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medically reported history provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE). On 28-Jan-2021, the patient experienced SKIN DISCOLOURATION (SKIN DECOLORATION). The patient was treated with CORTISONE at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (SHORTNESS OF BREATH), PALPITATIONS (HEART PALPITATIONS), SKIN DISCOLOURATION (SKIN DECOLORATION), INJECTION SITE WARMTH (HOT TO THE TOUCH INJECTION SITE), INJECTION SITE PRURITUS (ITCHINESS AT INJECTION SITE), INJECTION SITE RASH (RASH AT INJECTION SITE) and INJECTION SITE ERYTHEMA (REDNESS AT INJECTION SITE) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: An additional document received on 16 Apr 2021 included reported email address updated
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; A spontaneous report  was received from a consumer concerning a 50-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and tested positive for covid-19.  The patient's medical history was not provided. Concomitant medications included garlic, vitamin D3, bupropion hydrochloride, estradiol, progesterone, (ascorbic acid, ergocalciferol, nicotinamide, retinol palmitate, riboflavin, thiamine mononitrate), valacyclovir, useritin, NAC supplement and zinc.  On 18 Jan 2021, approximately five day prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (batch number: 013L2OA) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 22 Jan 2021, the patient tested positive for covid-19. The patient did not receive any treatment.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event tested positive for covid-19 was not reported.; Reporter's Comments: Very limited information regarding the events has been provided at this time.  Further information has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of COVID-19 (got sick with COVID) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Hydrocortisone and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced COVID-19 (got sick with COVID). The patient was treated with METHYLPREDNISOLONE SODIUM SUCCINATE (SOLUMEDROL) at an unspecified dose and frequency. At the time of the report, COVID-19 (got sick with COVID) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   IV fluids, Solumedrol used as a treatment medication
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Pain at Injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at Injection arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain at Injection arm). At the time of the report, INJECTION SITE PAIN (Pain at Injection arm) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Toothache
Clinical narrative: It is lower jaw that is swollen; Lower teeth has pain there / it has gotten worse since Saturday; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Historical condition reported.).    On 23-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday). At the time of the report, SWELLING FACE (It is lower jaw that is swollen) and TOOTHACHE (Lower teeth has pain there / it has gotten worse since Saturday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications were reported. Upon in internal review on 21 May 2021, the age was corrected to unknown age.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Peripheral swelling, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: my arm turned beet red; arm started to itch; swollen; hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch). On 30-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (my arm turned beet red). At the time of the report, INJECTION SITE ERYTHEMA (my arm turned beet red), VACCINATION SITE PRURITUS (arm started to itch), PERIPHERAL SWELLING (swollen) and VACCINATION SITE WARMTH (hot to touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm). At the time of the report, VACCINATION COMPLICATION (COVID arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Myalgia
Clinical narrative: pains in her left side about 2 inches above her waist that went around to her back; shingles; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026l20A) for COVID-19 vaccination.     The patient's past medical history included Cancer and Lymphedema. Concomitant products included LISINOPRIL and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles). The patient was treated with FAMCICLOVIR at an unspecified dose and frequency. At the time of the report, MYALGIA (pains in her left side about 2 inches above her waist that went around to her back) and HERPES ZOSTER (shingles) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Arm was hurting; Bad injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of   in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and HYDRALAZINE HYDROCHLORIDE (DIAZIDE [HYDRALAZINE HYDROCHLORIDE]) for an unknown indication.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     NO MEDICAL HISTORY WAS GIVEN.  The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction). At the time of the report, HYPERSENSITIVITY (allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No specific follow-up information recorded.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Blood glucose increased, Pain in extremity
Clinical narrative: arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L208) for COVID-19 vaccination.     The patient's past medical history included Diabetic since an unknown date. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), QUETIAPINE FUMARATE (SEROQUEL), GLUCAGON (BAQSIMI), MODAFINIL, TROSPIUM, CLOPIDOGREL BISULFATE (PLAVIX), ATORVASTATIN CALCIUM (LIPITOR), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), BUPROPION HYDROCHLORIDE (WELLBUTRIN), GABAPENTIN, HYDROXYZINE, DULOXETINE HYDROCHLORIDE (CYMBALTA), DICYCLOVERINE HYDROCHLORIDE (BENTYL), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and INSULIN ASPART (NOVOLOG) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt). At the time of the report, PAIN IN EXTREMITY (arm hurt) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Blood glucose decreased: 200 (Inconclusive) sugars were running about 200. On 28-Jan-2021, Blood glucose increased: 300 (Inconclusive) sugars were around 300 and are typically 126.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided by the reporter.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Muscle spasms
Clinical narrative: Muscle cramps in back; Feeling a little foggy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling a little foggy) and MUSCLE SPASMS (Muscle cramps in back) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Kidney disorder.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced FEELING ABNORMAL (Feeling a little foggy). On 19-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle cramps in back). On 20-Jan-2021, FEELING ABNORMAL (Feeling a little foggy) had resolved. At the time of the report, MUSCLE SPASMS (Muscle cramps in back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment for the events included Tylenol   This case was linked to MOD21-019546, MOD21-041828 (Linked Report).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: NNI; Sender's Comments:  MOD21-019546:crosslinked MOD21-041828:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: wide spread body aches; left bicep red and purple colored.; inflammed lymph nodes down the left side of my body; chills; slight headache; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills) and HEADACHE (slight headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever). At the time of the report, PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: wide spread body aches; left bicep red and purple colored.; inflammed lymph nodes down the left side of my body; chills; slight headache; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills) and HEADACHE (slight headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever). At the time of the report, PAIN (wide spread body aches), VACCINATION SITE PRURITUS (left bicep red and purple colored.), LYMPHADENOPATHY (inflammed lymph nodes down the left side of my body), CHILLS (chills), HEADACHE (slight headache) and PYREXIA (Slight fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided by the reporter.